A trio of influential medical professional associations issued a press release to express their strong opposition to the “ordering, prescribing, or dispensing of ivermectin to prevent or treat COVID-19 outside of a clinical trial.” TrialSite suggests the medical establishment, including the FDA, CDC, and growing numbers of medical societies, are now circling the wagons on the independent physicians who have followed and interpreted positive research results predominantly in low-to-middle-income countries (LMICs). On the record, the American Medical Association (AMA), American Pharmacists Association (APhA), and American Society of Health-System Pharmacists represent the next attack on what could be the forthcoming surrender of the use of ivermectin as a tool in the war against COVID-19. TrialSite suspects movements are in the works to 1) punish physicians or pharmacists that dispense and prescribe the drug for the COVID-19 off-label indication and, if that doesn’t work, 2) potentially criminalize the use of the drug off label for use against COVID-19.
TrialSite offers a breakdown of the logic behind this recent strong declaration.
What spooks these preeminent physician ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).